Product NDC: | 0024-1562 |
Proprietary Name: | Plaquenil |
Non Proprietary Name: | Hydroxychloroquine Sulfate |
Active Ingredient(s): | 200 mg/1 & nbsp; Hydroxychloroquine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-1562 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA009768 |
Marketing Category: | NDA |
Start Marketing Date: | 19550418 |
Package NDC: | 0024-1562-10 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0024-1562-10) |
NDC Code | 0024-1562-10 |
Proprietary Name | Plaquenil |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0024-1562-10) |
Product NDC | 0024-1562 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydroxychloroquine Sulfate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19550418 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | HYDROXYCHLOROQUINE SULFATE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antirheumatic Agent [EPC] |